Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 1;110(2):481-484.
doi: 10.3324/haematol.2024.285291.

Epigenetic age acceleration in hematopoietic stem cell transplantation

Margherita Ursi  1 , Katarzyna Malgorzata Kwiatkowska  2 , Chiara Pirazzini  2 , Gianluca Storci  3 , Daria Messelodi  3 , Salvatore Nicola Bertuccio  3 , Serena De Matteis  3 , Francesco Iannotta  3 , Enrica Tomassini  3 , Marcello Roberto  2 , Maria Naddeo  3 , Noemi Laprovitera  3 , Irene Salamon  3 , Barbara Sinigaglia  3 , Elisa Dan  3 , Francesco De Felice  1 , Francesco Barbato  1 , Enrico Maffini  3 , Sadia Falcioni  3 , Mario Arpinati  3 , Manuela Ferracin  1 , Massimiliano Bonafè  4 , Paolo Garagnani  1 , Francesca Bonifazi  1
Affiliations

Epigenetic age acceleration in hematopoietic stem cell transplantation

Margherita Ursi et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age acceleration throughout the first year. Age acceleration expressed as a continuous variable in recipients versus donors (A) at baseline and (B) in recipients (donors’ cells) throughout the first year post transplant; by Mann-Whitney and Cramer V test, respectively. KW: Kruskal-Wallis test.
Figure 2.
Figure 2.
Age acceleration and acute graft-versus-host disease. Age acceleration (AA) expressed as percentage throughout the transplantation time in (A) all patients, (B) those who developed acute graft-versus-host disease (GvHD), or (C) those who did not develop acute GvHD.
See this image and copyright information in PMC

References

    1. Maffini E, Ngoya M, Galimard JE, et al. . Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2023;58(9):1033-1041. - PubMed
    1. Sorror ML, Maris MB, Storb R, et al. . Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912-2919. - PMC - PubMed
    1. Li X, Ploner A, Wang Y, Magnusson PK, et al. . Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up. Elife. 2020;9:e51507. - PMC - PubMed
    1. Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023;29(5):1221-1231. - PubMed
    1. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. - PMC - PubMed

LinkOut - more resources